Review



anti col3a1  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc anti col3a1
    Anti Col3a1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/COL3A1+XP+Rabbit+mAb/10__3390_slash_cosmetics12060260-80-31-33
    Average 93 stars, based on 10 article reviews
    anti col3a1 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Formalin-fixed Paraffin-Embedded:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Gene Expression:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    RNA Sequencing:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Sequencing:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Biomarker Discovery:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Clinical Proteomics:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Microarray:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Control:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Immunohistochemistry:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Microscopy:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Immunofluorescence:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.

    Software:

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma
    Article Snippet: Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.Rabbit anti-human COL1A2 IgG antibody , sc-393573 , Santa Cruz Biotechnology.. Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.. Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.Rabbit anti-human FN1 IgG antibody , #26836S , Cell Signaling Technology.



    Similar Products

    93
    Cell Signaling Technology Inc anti col3a1
    Anti Col3a1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/COL3A1+XP+Rabbit+mAb/10__3390_slash_cosmetics12060260-80-31-33
    Average 93 stars, based on 1 article reviews
    anti col3a1 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    ATCC 7f streptococcus pneumoniae serotype 3 atcc
    7f Streptococcus Pneumoniae Serotype 3 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/BSClambda2%2E4/fda_document____cdrh_docs_slash_reviews_slash_k191967-105-14-19
    Average 90 stars, based on 1 article reviews
    7f streptococcus pneumoniae serotype 3 atcc - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    ATCC x 104 2x 2 2 streptococcus pneumoniae serotype 5 atcc
    X 104 2x 2 2 Streptococcus Pneumoniae Serotype 5 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/BSClambda2%2E4/fda_document____cdrh_docs_slash_reviews_slash_k191967-105-22-30
    Average 90 stars, based on 1 article reviews
    x 104 2x 2 2 streptococcus pneumoniae serotype 5 atcc - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc col 3
    Col 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/COL3A1+XP+Rabbit+mAb/pm40929956-48-36-38
    Average 93 stars, based on 1 article reviews
    col 3 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc col3a1
    Fig. 6 Prognostic value of LYZ and LILRB4 proteins in DLBCL receiving R-CHOP (n = 37, 10X) and aNSCLC receiving ICIs (n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the <t>COL3A1</t> expression and FN1+ mac- rophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclo- phosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival
    Col3a1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/COL3A1+XP+Rabbit+mAb/pm39998673-136-18-22
    Average 93 stars, based on 1 article reviews
    col3a1 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc 63034s
    Reagents and tools table
    63034s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/COL3A1+XP+Rabbit+mAb/pmc11861843-54-6-8
    Average 93 stars, based on 1 article reviews
    63034s - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc rabbit anti human col3a1 igg antibody
    Prognostic value of LYZ and LILRB4 proteins in DLBCL receiving R-CHOP ( n = 37, 10X) and aNSCLC receiving ICIs ( n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the <t>COL3A1</t> expression and FN1 + macrophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival
    Rabbit Anti Human Col3a1 Igg Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/COL3A1+XP+Rabbit+mAb/pmc11861843-54-0-8
    Average 93 stars, based on 1 article reviews
    rabbit anti human col3a1 igg antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    RWD Life Science mwm 63034
    Results of the <t>Morris</t> <t>Water</t> <t>Maze</t> test. (A) Representative path patterns of WT and UTX cKO mice in spatial learning trials and probe memory trials. Empty circles in the first quadrant indicate hidden platform locations. Escape latencies (B) and platform cross times (C) were compared between the WT and UTX cKO groups by Student's t ‐test. All data were expressed as mean ± SD ( n = 6). * p < 0.05, ** p < 0.01 versus WT group.
    Mwm 63034, supplied by RWD Life Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/63034s/mwm+test/pmc11710934-55-1-3
    Average 90 stars, based on 1 article reviews
    mwm 63034 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 6 Prognostic value of LYZ and LILRB4 proteins in DLBCL receiving R-CHOP (n = 37, 10X) and aNSCLC receiving ICIs (n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the COL3A1 expression and FN1+ mac- rophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclo- phosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival

    Journal: Cancer immunology, immunotherapy : CII

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma.

    doi: 10.1007/s00262-025-03968-7

    Figure Lengend Snippet: Fig. 6 Prognostic value of LYZ and LILRB4 proteins in DLBCL receiving R-CHOP (n = 37, 10X) and aNSCLC receiving ICIs (n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the COL3A1 expression and FN1+ mac- rophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclo- phosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival

    Article Snippet: Primary antibodies included rabbit anti-human IgG antibody LYZ (ab108508, dilution 1:2000, Abcam), LILRB4 (#55107, dilution 1:2000, Signalway Antibody), COL3A1 (#63034S, dilution 1:3000, Cell Signaling Technology), FN1 (#26836S, dilution 1:2000, Cell Signaling Technology), CD68 (ab303565, dilution 1:1000, Abcam), and mouse anti-human pan-cytokeratin IgG antibody (GB122053, dilution 1:2000, Servicebio) and COL1A2 (sc-393573, dilution 1:2000, Santa Cruz Biotechnology).

    Techniques: Staining, Expressing, Immunohistochemistry, Immunofluorescence

    Reagents and tools table

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma

    doi: 10.1007/s00262-025-03968-7

    Figure Lengend Snippet: Reagents and tools table

    Article Snippet: Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.

    Techniques: Formalin-fixed Paraffin-Embedded, Gene Expression, RNA Sequencing, Sequencing, Biomarker Discovery, Clinical Proteomics, Microarray, Control, Immunohistochemistry, Microscopy, Immunofluorescence, Software

    Prognostic value of LYZ and LILRB4 proteins in DLBCL receiving R-CHOP ( n = 37, 10X) and aNSCLC receiving ICIs ( n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the COL3A1 expression and FN1 + macrophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma

    doi: 10.1007/s00262-025-03968-7

    Figure Lengend Snippet: Prognostic value of LYZ and LILRB4 proteins in DLBCL receiving R-CHOP ( n = 37, 10X) and aNSCLC receiving ICIs ( n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the COL3A1 expression and FN1 + macrophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival

    Article Snippet: Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.

    Techniques: Staining, Expressing, Immunohistochemistry, Immunofluorescence

    Prognostic significance of autoantibodies against COL1A2, COL3A1, and FN1 in patients with DLBCL receiving R-CHOP ( n = 20 and 125) and NSCLC treated with ICIs ( n = 36). A Volcano plot, boxplot, and representative density plots of patients illustrating the distribution of COL1A2 autoantibodies in DLBCL. B Kaplan–Meier curve for PFS based on COL1A2 autoantibody levels in DLBCL. C Kaplan–Meier curves for OS and PFS in NSCLC patients receiving immunotherapy, stratified by COL1A2 and COL3A1 mRNA levels in GSE128989 and autoantibody presence, alongside representative density plots of COL1A2 and COL3A1 autoantibodies. D Comparison of FN1 autoantibody levels between healthy controls and DLBCL, with Kaplan–Meier analysis for PFS based on FN1 autoantibody levels. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin: vincristine, and prednisone; NSCLC: non-small cell lung cancer; ICIs: immune checkpoint inhibitor; OS: overall survival; and PFS: progression-free survival

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma

    doi: 10.1007/s00262-025-03968-7

    Figure Lengend Snippet: Prognostic significance of autoantibodies against COL1A2, COL3A1, and FN1 in patients with DLBCL receiving R-CHOP ( n = 20 and 125) and NSCLC treated with ICIs ( n = 36). A Volcano plot, boxplot, and representative density plots of patients illustrating the distribution of COL1A2 autoantibodies in DLBCL. B Kaplan–Meier curve for PFS based on COL1A2 autoantibody levels in DLBCL. C Kaplan–Meier curves for OS and PFS in NSCLC patients receiving immunotherapy, stratified by COL1A2 and COL3A1 mRNA levels in GSE128989 and autoantibody presence, alongside representative density plots of COL1A2 and COL3A1 autoantibodies. D Comparison of FN1 autoantibody levels between healthy controls and DLBCL, with Kaplan–Meier analysis for PFS based on FN1 autoantibody levels. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin: vincristine, and prednisone; NSCLC: non-small cell lung cancer; ICIs: immune checkpoint inhibitor; OS: overall survival; and PFS: progression-free survival

    Article Snippet: Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.

    Techniques: Comparison

    Reagents and tools table

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma

    doi: 10.1007/s00262-025-03968-7

    Figure Lengend Snippet: Reagents and tools table

    Article Snippet: Rabbit anti-human COL3A1 IgG antibody , #63034S , Cell Signaling Technology.

    Techniques: Formalin-fixed Paraffin-Embedded, Gene Expression, RNA Sequencing, Sequencing, Biomarker Discovery, Clinical Proteomics, Microarray, Control, Immunohistochemistry, Microscopy, Immunofluorescence, Software

    Results of the Morris Water Maze test. (A) Representative path patterns of WT and UTX cKO mice in spatial learning trials and probe memory trials. Empty circles in the first quadrant indicate hidden platform locations. Escape latencies (B) and platform cross times (C) were compared between the WT and UTX cKO groups by Student's t ‐test. All data were expressed as mean ± SD ( n = 6). * p < 0.05, ** p < 0.01 versus WT group.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: Untargeted Metabolomics Reveals Metabolic Link Between Histone H3K27 Demethylase UTX and Neurodevelopment

    doi: 10.1111/jcmm.70334

    Figure Lengend Snippet: Results of the Morris Water Maze test. (A) Representative path patterns of WT and UTX cKO mice in spatial learning trials and probe memory trials. Empty circles in the first quadrant indicate hidden platform locations. Escape latencies (B) and platform cross times (C) were compared between the WT and UTX cKO groups by Student's t ‐test. All data were expressed as mean ± SD ( n = 6). * p < 0.05, ** p < 0.01 versus WT group.

    Article Snippet: The MWM (63034, RWD Life Science, China) is a circular tank (120 cm diameter, 50 cm height) filled with opaque water (23°C ± 2°C) up to 20 cm and divided into four equidistant quadrants: the first, second, third, and fourth quadrants, with a transparent platform 1 cm below the water surface in a fixed location (the first quadrant).

    Techniques: